Covered recipient · General Payments record
KIMBERLY R CRAY
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$2,778.83
- Reported across 91 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $986.05 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | $540.52 | 5 |
| ABBVIE INC. | $204.96 | 12 |
| Incyte Corporation | $160.32 | 3 |
| Galderma Laboratories, L.P. | $22.19 | 1 |
| Amgen Inc. | $21.93 | 1 |
| Arcutis Biotherapeutics, Inc. | $18.60 | 1 |
| Janssen Biotech, Inc. | $17.53 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.59 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106965200 | CMS |
| ABBVIE INC. | $10.22 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106965202 | CMS |
| ABBVIE INC. | $10.36 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106965204 | CMS |
| ABBVIE INC. | $42.32 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106965206 | CMS |
| ABBVIE INC. | $15.65 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106965208 | CMS |
| ABBVIE INC. | $20.26 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106965210 | CMS |
| ABBVIE INC. | $30.08 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106965212 | CMS |
| ABBVIE INC. | $29.18 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106965214 | CMS |
| ABBVIE INC. | $10.12 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106965216 | CMS |
| ABBVIE INC. | $9.95 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106965218 | CMS |
| ABBVIE INC. | $7.73 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106965220 | CMS |
| ABBVIE INC. | $6.50 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106965222 | CMS |
| Amgen Inc. | $21.93 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117533556 | CMS |
| Arcutis Biotherapeutics, Inc. | $18.60 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121105922 | CMS |
| Galderma Laboratories, L.P. | $22.19 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145351767 | CMS |
| Incyte Corporation | $23.90 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141313161 | CMS |
| Incyte Corporation | $11.42 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141261779 | CMS |
| Incyte Corporation | $125.00 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141222586 | CMS |
| Janssen Biotech, Inc. | $17.53 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078449660 | CMS |
| REVANCE THERAPEUTICS, INC. | $139.51 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147937255 | CMS |
| REVANCE THERAPEUTICS, INC. | $64.53 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147937257 | CMS |
| REVANCE THERAPEUTICS, INC. | $174.78 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147937259 | CMS |
| REVANCE THERAPEUTICS, INC. | $130.40 | 08/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147937261 | CMS |
| REVANCE THERAPEUTICS, INC. | $31.30 | 08/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147937263 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.